Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles

Li,Ai‑Jun; Zheng,Yue‑Hua; Liu,Guo‑Dong; Liu,Wei‑Sheng; Cao,Pei‑Cheng; Bu,Zhen‑Fu

doi:10.3892/mmr.2014.3017

Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles

Authors:
- Ai‑Jun Li
- Yue‑Hua Zheng
- Guo‑Dong Liu
- Wei‑Sheng Liu
- Pei‑Cheng Cao
- Zhen‑Fu Bu
View Affiliations

Affiliations: Department of Neurosurgery, Weifang People's Hospital, Weifang, Shandong 261021, P.R. China, Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China
Published online on: November 28, 2014 https://doi.org/10.3892/mmr.2014.3017
Pages: 3078-3086

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The treatment of glioblastoma, and other types of brain cancer, is limited due to the poor transport of drugs across the blood brain barrier and poor penetration of the blood‑brain‑tumor barrier. In the present study, cyclic Arginine‑Glycine‑Aspartic acid‑D‑Tyrosine‑Lysine [c(RGDyK)], that has a high binding affinity to integrin αvβ3 receptors, that are overexpressed in glioblastoma cancers, was employed as a novel approach to target cancer by delivering therapeutic molecules intracellularly. The c(RGDyK)/docetaxel polylactic acid‑polyethylene glycol (DTX‑PLA‑PEG) micelle was prepared and characterized for various in vitro and in vivo parameters. The specific binding affinity of the Arginine‑Glycine‑Aspartic acid (RGD) micelles, to the integrin receptor, enhanced the intracellular accumulation of DTX, and markedly increased its cytotoxic efficacy. The effect of microtubule stabilization was evident in the inhibition of glioma spheroid volume. Upon intravenous administration, c(RGDyK)/DTX‑PLA‑PEG showed enhanced accumulation in brain tumor tissues through active internalization, whereas non‑targeted micelles showed limited transport ability. Furthermore, RGD‑linked micelles showed marked anti‑glioma activity in U87MG malignant glioma tumor xenografts, and significantly suppressed the growth of tumors without signs of systemic toxicity. In conclusion, the results of the present study suggest that ligand‑mediated drug delivery may improve the efficacy of brain cancer chemotherapy.

View Figures

View References

1	Jain RK, di Tomaso E, Duda DG, et al: Angiogenesis in brain tumors. Nat Rev Neurosci. 8:610–622. 2007. View Article : Google Scholar : PubMed/NCBI
2	Ong BY, Ranganath SH, Lee LY, et al: Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials. 30:3189–3196. 2009. View Article : Google Scholar : PubMed/NCBI
3	Wen PY and Kesari S: Malignant Gliomas in Adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
4	Jones TS and Holland EC: Standard of care therapy for malignant glioma and its effect on tumor and stromal cells. Oncogene. 31:1995–2006. 2012. View Article : Google Scholar
5	Rich JN and Bigner DD: Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 3:430–446. 2004. View Article : Google Scholar : PubMed/NCBI
6	Ningaraj NS: Drug delivery to brain tumours: challenges and progress. Expert Opin Drug Deliv. 3:499–509. 2006. View Article : Google Scholar : PubMed/NCBI
7	Sarin H: Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med. 7:772009. View Article : Google Scholar : PubMed/NCBI
8	Xin H, Sha X, Jiang X, Zhang W, Chen L and Fang X: Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials. 33:8167–8176. 2012. View Article : Google Scholar : PubMed/NCBI
9	Gu G, Xia H, Hu Q, et al: PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Biomaterials. 34:196–208. 2013. View Article : Google Scholar
10	Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R and Langer R: Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2:751–760. 2007. View Article : Google Scholar
11	Danhier F, Le Breton AL and Préat V: RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm. 9:2961–2973. 2012. View Article : Google Scholar : PubMed/NCBI
12	Schottelius M, Laufer B, Kessler H and Wester HJ: Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res. 42:969–980. 2009. View Article : Google Scholar : PubMed/NCBI
13	Chen X, Park R, Shahinian AH, et al: 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 31:179–189. 2004. View Article : Google Scholar : PubMed/NCBI
14	Chen X, Hou Y, Tohme M, et al: Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med. 45:1776–1783. 2004.PubMed/NCBI
15	Gajbhiye V and Jain NK: The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates. Biomaterials. 32:6213–6225. 2011.PubMed/NCBI
16	Nasongkla N, Bey E, Ren J, et al: Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6:2427–2430. 2006. View Article : Google Scholar : PubMed/NCBI
17	Zhan C, Gu B, Xie C, Li J, Liu Y and Lu W: Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release. 143:13620–142. 2010. View Article : Google Scholar
18	Ramasamy T, Khandasami US, Ruttala H and Shanmugam S: Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res. 20:682–692. 2012. View Article : Google Scholar
19	Carrion C, de Madariaga MA and Domingo JC: In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells. Life Sci. 75:313–328. 2004. View Article : Google Scholar : PubMed/NCBI
20	Carvalho JC, Perazzo FF, Machado L and Bereau D: Biologic activity and biotechnological development of natural products. BioMed Res Int. 2013:9717452013. View Article : Google Scholar
21	Gupta B and Torchilin VP: Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice. Cancer Immunol Immunother. 56:1215–1223. 2007. View Article : Google Scholar : PubMed/NCBI
22	Liu J and Shapiro JI: Endocytosis and signal transduction: basic science update. Biol Res Nurs. 5:117–128. 2003. View Article : Google Scholar : PubMed/NCBI
23	Jiang X, Sha X, Xin H, et al: Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials. 32:9457–9469. 2011. View Article : Google Scholar : PubMed/NCBI
24	Jiang X, Sha X, Xin H, et al: Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel. Biomaterials. 34:2969–2979. 2013. View Article : Google Scholar : PubMed/NCBI
25	Downing KH and Nogales E: Tubulin and microtubule structure. Curr Opin Cell Biol. 10:16–22. 1998. View Article : Google Scholar : PubMed/NCBI
26	Miller ML and Ojima I: Chemistry and chemical biology of taxane anticancer agents. Chem Rec. 1:195–211. 2001. View Article : Google Scholar
27	Gao H, Yang Z, Zhang S, et al: Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. J Control Release. 172:921–928. 2013. View Article : Google Scholar : PubMed/NCBI
28	Kanazawa T, Taki H, Tanaka K, Takashima Y and Okada H: Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration. Pharm Res. 28:2130–2139. 2011. View Article : Google Scholar : PubMed/NCBI
29	Zhao H, Wang JC, Sun QS, et al: RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer. J Drug Target. 17:10–18. 2009. View Article : Google Scholar
30	Saad M, Garbuzenko OB, Ber E, et al: Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J Control Release. 130:107–114. 2008. View Article : Google Scholar : PubMed/NCBI